Suppr超能文献

β-肾上腺素能受体阻断药的选择性作用及β1和β2肾上腺素能受体的性质。

The selective action of beta-adrenoceptor blocking drugs and the nature of beta1 and beta2 adrenoceptors.

作者信息

Coleman A J, Somerville A R

出版信息

Br J Pharmacol. 1977 Jan;59(1):83-93. doi: 10.1111/j.1476-5381.1977.tb06980.x.

Abstract

1 Purified membranes retaining a catecholamine responsive adenylate cyclase have prepared from rabbit heart, lung and (pseudo-pregnant) uterus. 2 These preparations have the characteristics of plasma membranes and both heart and lung respond to beta-adrenoceptor agonists in the order: (+/-)-isoprenaline greater than (-)-noradrenaline greater than (-)-adrenaline greater than (+)-isoprenaline greater than salbutamol. The sensitivity of the adenylate cyclase to beta-adrenoceptor stimulation is improved by pre-treatment of the animals with reserpine and syrosingopine. 3 Dose-ratios for several concentrations of propranolol (non-selective beta-adrenoceptor blocker), practolol and atenolol (cardio-selective beta-adrenoceptor blockers) have been measured on all three membrane preparations. Schild plots of log (dose ratio -1) vs. log dose were virtually coincident for heart and lung with a dissociation constant (Kb) for propranolol very close to the pharmacological value. The ratio of Kb values was 0.65 for practolol and 1.23 for atenolol compared with pharmacological cardio-selectivity ratios (measured on isolated atria and tracheal chain) of 67.6 and 110 respectively. The uterus/heart Kb ratio was 51.5 for atenolol. Inhibition of the uterus by practolol gave a Schild plot with slope significantly less than 1, indicating a different mechanism of action from the heart. 4 Kb values obtained by measuring adenylate cyclase stimulation in chopped tissue (including preparations of bronchial tree and alveolar tissue as well as whole lung) resembled the membrane values rather than those found in whole organs. 5 The results show that the pharmacological selectivity of practolol and atenolol is maintained at the receptor-adenylate cyclase level, at least as far as heart and uterus are concerned, though the smaller selectivity ratios in the biochemical system suggest that receptor differences is not the only factor and that phase distribution of the drug may also be important. Membranes prepared from whole lung show that phase distribution of the drug may also be important. Membranes prepared from whole lung show an overall beta1 response which may simply reflect the predominance of beta1 cell types containing beta1-adrenoceptors over bronchial smooth muscle.

摘要
  1. 已从兔心脏、肺和(假孕)子宫制备出保留有对儿茶酚胺有反应的腺苷酸环化酶的纯化膜。2. 这些制剂具有质膜的特性,心脏和肺对β-肾上腺素能受体激动剂的反应顺序为:(±)-异丙肾上腺素>(-)-去甲肾上腺素>(-)-肾上腺素>(+)-异丙肾上腺素>沙丁胺醇。用利血平和蛇根亭宁预处理动物可提高腺苷酸环化酶对β-肾上腺素能受体刺激的敏感性。3. 已在所有三种膜制剂上测定了几种浓度的普萘洛尔(非选择性β-肾上腺素能受体阻滞剂)、普拉洛尔和阿替洛尔(心脏选择性β-肾上腺素能受体阻滞剂)的剂量比。心脏和肺的log(剂量比 -1)对log剂量的希尔德图几乎重合,普萘洛尔的解离常数(Kb)非常接近药理学值。普拉洛尔的Kb值之比为0.65,阿替洛尔为1.23,而药理学心脏选择性比(在离体心房和气管链上测定)分别为67.6和110。阿替洛尔的子宫/心脏Kb比为51.5。普拉洛尔对子宫的抑制作用产生的希尔德图斜率明显小于1,表明其作用机制与心脏不同。4. 通过测量切碎组织(包括支气管树和肺泡组织以及全肺制剂)中的腺苷酸环化酶刺激获得的Kb值类似于膜的值,而不是在整个器官中发现的值。5. 结果表明,至少就心脏和子宫而言,普拉洛尔和阿替洛尔的药理学选择性在受体 - 腺苷酸环化酶水平上得以维持,尽管生化系统中较小的选择性比表明受体差异不是唯一因素,药物的相分布可能也很重要。从全肺制备的膜表明药物的相分布可能也很重要。从全肺制备的膜显示出总体β1反应,这可能仅仅反映了含有β1-肾上腺素能受体的β1细胞类型相对于支气管平滑肌的优势。

相似文献

5
A study of beta-adrenoceptors in rat lung parenchymal strip.大鼠肺实质条中β-肾上腺素能受体的研究。
J Pharm Pharmacol. 1989 May;41(5):357-9. doi: 10.1111/j.2042-7158.1989.tb06476.x.

引用本文的文献

5
beta-Adrenoreceptor antagonists in essential tremor.β-肾上腺素能受体拮抗剂治疗特发性震颤
J Neurol Neurosurg Psychiatry. 1979 Oct;42(10):904-9. doi: 10.1136/jnnp.42.10.904.

本文引用的文献

2
Drug antagonism and pAx.药物拮抗作用与pAx
Pharmacol Rev. 1957 Jun;9(2):242-6.
5
Selective blockade of adrenoceptive beta receptors in the heart.心脏中肾上腺素能β受体的选择性阻断。
Br J Pharmacol Chemother. 1968 Jan;32(1):201-18. doi: 10.1111/j.1476-5381.1968.tb00444.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验